Effective emergency response to a natural disaster requires rapid, coordinated action among multiple parties. Suffice to say that such a level of efficiency has been sadly lacking in many prior relief efforts. Can blockchain make it happen?
Streamlining the pharmaceutical supply chain and getting more generic drugs to market would help consumers who can’t afford prescriptions, the head of the U.S. Senate’s special committee on aging says.
A nonprofit founded to address a pressing U.S. health-care problem by manufacturing much-needed drugs that have fallen into short supply, or that are too expensive, will start out with a different approach: buying the drugs from pharmaceutical companies.
Life science and business are going to meet at PHARM Connect on the 12-13 of March 2019 in Budapest, Hungary to continue the tradition of providing high calibre, customised professional partnering opportunities for pharma and biotech professionals from Central & Eastern European and beyond and deliver the crucial information they need to excel in their work. The influential annual gathering brings together over 400 global and regional decision-makers, top scientists, industry executives and business development leaders for the ninth time to identify new business opportunities, technologies, state-of-the-art formulation development strategies and to foster exchange of ideas on the role of the sector.
McKesson Corp., one of the largest U.S. drug distributors, sent pharmacies prescription opioids that had been removed from their bottles and replaced with over-the-counter painkillers, the Food and Drug Administration says.
Concerns about quality control and data integrity have focused on companies in India and China, where more and more ingredients used in medicine for the U.S. are being made. But those concerns aren’t limited to overseas factories, according to a year-long investigation into FDA’s regulation of the generic-drug industry.